
SEVERE FORM OF SALIH MYOPATHY CAUSED BY COMBINATION OF TWO HETEROZYGOUS TTN MUTATIONS Milojković M, Jarić M, Stojanović V, Barišić N, Kavečan I *Corresponding Author: Assistant Milica Milojkovic, MD, PhD, Institute for Child and Youth Health Care of Vojvodina, Hajduk Veljkova 10, 21000 Novi Sad, Serbia; e-mail: milica.milojkovic@mf.uns.ac.rs page: 73
|
DISCUSSION
Salih myopathy is relatively new entity, so it is dif-
ficult for clinicians to distinguish congenital titinopathies
from congenital myopathies associated with other genes
(7,8). With that in mind, the diagnostic approach excluded
some of the more common causes of hypotonia in children
and suspected a rare cause.
Salih myopathy is characterized by muscle weak-
ness, hypotonia that manifests itself in the neonatal period
or early childhood. According to Hackam et al., affected
children walk between the ages of 20 months and 4 years,
with a tendency for motor functions to improve (3). In
contrast, our reported child is 2 years old, without spon-
taneous movements, with the same motor functions as at
birth, and is dependent on invasive respiratory support.
Contractures and deformities of the foot are common
in patients with titinopathies, localized distally and affect-
ing more than two joints, appearing in the first decade of
life (7, 9). Unlike joint contractures and foot deformities,
multiple fractures are rare. According to data from the lit-
erature, fractures were described only in two patients until
now (10). So far, there are no reported multiple fractures
in the neonatal period as our patient had.
Cases are described where mechanical support was
needed only at birth and with further progression of the
disease. This was performed intermittently only during
the night (10). Unlike patients found in the literature, our
patient has been on invasive respiratory support from birth.
According to data from the literature, dilated cardio-
myopathy can occur in patients at the age of 4 months,
but most often between 5 and 16 years of age (11,12,13).
The echocardiographic examination of our patient is still
normal.
There are no specific laboratory and radiological find-
ings that can be used to diagnose Salih myopathy. Creatine
kinase may be at the upper limit of normal or elevated
(generally 1.5-7x elevated) (3). Similarly, creatine kinase
in our case was initially elevated, 1.7x above the upper
limit, and later normal. In the literature, EMNG findings
of patients are reported, indicating a polyphasic potential
of low amplitude of short duration (3). The same finding
was obtained in our patient.
The findings of muscle biopsies in patients with ti-
tinopathies are pathological. The changes that can be ob-
served are increased fiber size variation, centrally placed
cores and cores with additional structural abnormalities
(10). In Salih myopathy, electron microscopy of skeletal
muscles reveals multiple foci of sarcomere disruption and
mitochondrial depletion (3). In our patient’s muscle biopsy,
no pathognomonic changes were registered to the extent
that they were diagnostic.
The intellectual development of children with Salih
myopathy is usually normal (3). Our patient is conscious,
establishes social contact, and a psychological examina-
tion shows gross retardation in psychomotor development,
most likely because of severe perinatal asphyxia (MRI),
most likely due to severe congenital hypotonia.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|